2007 Journal Article Clinimetric properties of participation measures for 5-to 13-year-old children with cerebral palsy: A systematic reviewSakzewski, Leanne, Boyd, Roslyn and Ziviani, Jenny (2007). Clinimetric properties of participation measures for 5-to 13-year-old children with cerebral palsy: A systematic review. Developmental Medicine and Child Neurology, 49 (3), 232-240. doi: 10.1111/j.1469-8749.2007.00232.x |
2007 Journal Article Psychometric properties of the quality of life questionnaire for children with CPWaters, Elizabeth, Davis, Elise, Mackinnon, Andrew, Boyd, Roslyn, Graham, H. Kerr, Lo, Sing Kai, Wolfe, Rory, Stevenson, Richard, Bjornson, Kristie, Blair, Eve and et al. (2007). Psychometric properties of the quality of life questionnaire for children with CP. Developmental Medicine & Child Neurology, 49 (1), 49-55. doi: 10.1017/S0012162207000126 |
2007 Journal Article Psychometric properties of the quality of life questionnaire for children with CPWaters, Elizabeth, Davis, Elise, Mackinnon, Andrew, Boyd, Roslyn, Graham, H. Kerr, Kai Lo, Sing, Wolfe, Rory, Stevenson, Richard, Bjornson, Kristie, Blair, Eve, Hoare, Peter, Ravens-sieberer, Ulrike and Reddihough, Dinah (2007). Psychometric properties of the quality of life questionnaire for children with CP. Developmental Medicine and Child Neurology, 49 (1), 49-55. doi: 10.1017/S0012162207000126.x |
2006 Journal Article Paediatric quality of life instruments: A review of the impact of the conceptual framework on outcomesDavis, Elise, Waters, Elizabeth, Mackinnon, Andrew, Reddihough, Dinah, Graham, H. Kerr, Mehmet-Radji, Ozlem and Boyd, Roslyn (2006). Paediatric quality of life instruments: A review of the impact of the conceptual framework on outcomes. Developmental Medicine & Child Neurology, 48 (4), 311-318. doi: 10.1017/S0012162206000673 |
2006 Journal Article Hip displacement in cerebral palsySoo, Brendan, Howard, Jason, J., Boyd, Roslyn N., Reid, Susan M., Lanigan, Anna, Wolfe, Rory, Reddihough, Dinah and Graham, H. Kerr (2006). Hip displacement in cerebral palsy. Journal of Bone and Joint Surgery: American volume, 88 (1), 121-129. doi: 10.2106/JBJS.E.00071 |
2005 Journal Article Cerebral palsy in Victoria: Motor types, topography and gross motor functionHoward, Jason, Soo, Brendan, Graham, H. Kerr, Boyd, Roslyn N., Reid, Sue, Lanigan, Anna, Wolfe, Rory and Reddihough, Dinah S. (2005). Cerebral palsy in Victoria: Motor types, topography and gross motor function. Journal of Paediatrics And Child Health, 41 (9-10), 479-483. doi: 10.1111/j.1440-1754.2005.00687.x |
2005 Journal Article Development of a condition-specific measure of quality of life for children with cerebral palsy: Empirical thematic data reported by parents and childrenWaters, E., Maher, E., Salmon, L., Reddihough, D. and Boyd, R. (2005). Development of a condition-specific measure of quality of life for children with cerebral palsy: Empirical thematic data reported by parents and children. Child: Care, Health and Development, 31 (2), 127-135. doi: 10.1111/j.1365-2214.2004.00476.x |
2004 Journal Article Gait patterns after fracture of the femoral shaft in children, managed by external fixation or early hip spica castWong, Justin, Boyd, Roslyn, Keenan, Nigel W., Baker, Richard, Selber, Paulo, Wright, James G., Nattrass, Gary R. and Graham, H. Kerr (2004). Gait patterns after fracture of the femoral shaft in children, managed by external fixation or early hip spica cast. Journal of Pediatric Orthopaedics, 24 (5), 463-471. |
2003 Journal Article Expression of the HPV16E7 oncoprotein by thymic epithelium is accompanied by disrupted T cell maturation and a failure of the thymus to involute with ageMalcolm, K. M., Gill, J., Leggatt, G. R., Boyd, R., Lambert, P. and Frazer, I. H. (2003). Expression of the HPV16E7 oncoprotein by thymic epithelium is accompanied by disrupted T cell maturation and a failure of the thymus to involute with age. Clinical and Developmental Immunology, 10 (2-4), 91-103. doi: 10.1080/10446670310001626562 |
2003 Journal Article Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?Graham, H. Kerr, Boyd, Roslyn N. and Fehlings, Darcy (2003). Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?. Medical Journal of Australia, 178 (2), 95-96. |
2003 Journal Article Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?Graham, HK, Boyd, RN and Fehlings, D (2003). Does intramuscular botulinum toxin A injection improve upper-limb function in children with hemiplegic cerebral palsy?. Medical Journal of Australia, 178 (2), 95-96. |
2002 Journal Article Hip displacement in spastic cerebral palsy: Repeatability of radiologic measurementParrott, Jennifer, Boyd, Roslyn N., Dobson, Fiona, Lancaster, Ann, Love, Sarah, Oates, Jenene, Wolfe, Rory, Nattrass, Gary R. and Graham, H. Kerr (2002). Hip displacement in spastic cerebral palsy: Repeatability of radiologic measurement. Journal of Pediatric Orthopaedics, 22 (5), 660-667. doi: 10.1097/01.BPO.0000023144.69745.67 |
2002 Journal Article Hip surveillance in children with cerebral palsy - Impact on the surgical management of spastic hip diseaseDobson, F., Boyd, R. N., Parrott, J., Nattrass, G. R. and Graham, H. K. (2002). Hip surveillance in children with cerebral palsy - Impact on the surgical management of spastic hip disease. Journal of Bone and Joint Surgery - Series B, 84B (5), 720-726. doi: 10.1302/0301-620X.84B5.12398 |
2002 Journal Article Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial Botolinum toksin A'nin analjezik etkileri: Rastgele gruplamali, plasebo kontrollü klinik çalişmaBarwood, S., Baillieu, C., Boyd, R., Brereton, K., Low, J., Nattrass, G. and Graham, H. Kerr (2002). Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial Botolinum toksin A'nin analjezik etkileri: Rastgele gruplamali, plasebo kontrollü klinik çalişma. Agri, 14 (3), 29-36. |
2000 Journal Article Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trialBarwood, S., Baillieu, C., Boyd, R., Brereton, K., Low, J., Nattrass, G. and Graham, H. K. (2000). Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial. Developmental Medicine and Child Neurology, 42 (2), 116-121. doi: 10.1111/j.1469-8749.2000.tb00056.x |
2000 Journal Article Recommendations for the use of botulinum toxin type A in the management of cerebral palsyGraham, H. K., Aoki, K. R., Autti-Ramo, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., Matthews, D., Molenaers, G., Motta, F., Ruiz, P. J. G. and Wissel, J. (2000). Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait and Posture, 11 (1), 67-79. doi: 10.1016/S0966-6362(99)00054-5 |
2000 Journal Article Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsyBoyd, R. N., Pliatsios, V., Starr, R., Wolfe, R. and Graham, H. K. (2000). Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Developmental Medicine and Child Neurology, 42 (1), 32-41. doi: 10.1111/j.1469-8749.2000.tb00022.x |
1999 Journal Article Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsyBoyd, R. N. and Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European Journal of Neurology, 6 (Suppl. 4), S23-S35. doi: 10.1111/j.1468-1331.1999.tb00031.x |
1999 Journal Article Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsyBoyd, R. N., Graham, J. E. A., Nattrass, G. R. and Graham, H. K. (1999). Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. European Journal of Neurology, 6 (S4), S37-S45. doi: 10.1111/j.1468-1331.1999.tb00033.x |
1999 Journal Article High- or low-technology measurements of energy expenditure in clinical gait analysis?Boyd, R., Fatone, S., Rodda, J., Olesch, C., Starr, R., Cullis, E., Gallagher, D., Carlin, J. B., Nattrass, G. R. and Graham, K. (1999). High- or low-technology measurements of energy expenditure in clinical gait analysis?. Developmental Medicine and Child Neurology, 41 (10), 676-682. doi: 10.1111/j.1469-8749.1999.tb00522.x |